Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CEL SCI CORP Prospectus 2018

Jun 29, 2018

34401_prs_2018-06-29_da9b59ee-41e6-4853-8c4d-e3138e536873.zip

Prospectus

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

424B3 1 cvm_ex424b3.htm PROSPECTUS SUPPLEMENT Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2018 Issuer Direct Corporation Blueprint

| PROSPECTUS
SUPPLEMENT | Filed
pursuant to Rule 424(b)(3) |
| --- | --- |
| (To Prospectus
Supplement dated December 8, 2016) | Registration No. 333-205444 |

CEL-SCI CORPORATION

Series DD and Series EE Warrants

On June 25, 2018 the Company extended the expiration date of its Series DD and Series EE warrants until the close of business on July 12, 2018. The Series DD and Series EE warrants were issued as part of a financing on December 8, 2016. As a result of the reverse stock split approved by the Company’s shareholders and adopted by the Company’s directors:

the holders of the Series DD warrants are entitled to purchase 1,360,960 shares of the Company’s common stock at an exercise price of $4.50 per share; and

the holders of the Series EE warrants are entitled to purchase 1,360,960 shares of the Company’s common stock at an exercise price of $4.50 per share.

Prospectus Supplement dated June 27, 2018

page break